Time of disease | Type of sample | BCR clonality (IGH) | IGVH identification | Open Reading Frame | Percentage of VH homology with germline sequence | Percentage of VH homology relative to diagnosis |
---|---|---|---|---|---|---|
Diagnosis | Lymph node | FR1+,a FR2-, FR3- | IGHV4–59*01, IGHD5–24*01, IGHJ4*02 | Yes | 87.27% | |
Second progression | Lymph node | FR1+,a FR2-, FR3- | IGHV4–59*01, IGHD5–24*01, IGHJ4*02 | Yes | 84.55%b | 96.9% |
Third progression | Ascites | FR1+,a FR2-, FR3- | IGHV4–59*01, IGHD5–24*01, IGHJ4*02 | Yes | 86.36% | 98.9% |